Catheter lock solution

TauroLock™ is suitable for central venous access within hemodialysis and oncology. Its dual effectiveness prevents catheter infections and clot formation.

Catheter lock solution

Taurolock Classic™

4% citrate (anti-clotting effect) and 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE)

Meer informatie »

TauroLock Hep100™

4% citrate (anti-clotting effect), 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE) and 100 units of heparin per ml (extra anticoagulant effect)

Meer informatie »

Taurolock Hep500™

4% citrate (anti-clotting effect), 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE) and 500 units of heparin per mL (extra anticoagulant effect)

Meer informatie »

Taurolock Urokinase™

4% citrate (anti-clotting effect), 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE) and 5000 IU/mL urokinase (intensive anticoagulant)

Meer informatie »

Catheter lock solution